Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-11-11 / Cancer Immunol. Immunother. 2011 Feb;60(2):249-60Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy
/in Breast Cancer, Hyperthermia, International Publications /von 2010-11-11 / Radiother Oncol 2010 Dec;97(3):535-40Combination of ionising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells
/in Colorectal Cancer, Hyperthermia, International Publications /von 2010-11-08 / Strahlenther Onkol 2010 Nov;186(11):587-99NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment
/in Hyperthermia, International Publications /von 2010-11-08 / Proc. Natl. Acad. Sci. U.S.A. 2010 Nov;107(47):20477-82Dendritic cell-based immunotherapy for prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-11-04 / Clin. Dev. Immunol. 2010;2010:517493Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer
/in International Publications, Newcastle Disease Virus /von 2010-11-04 / Head Neck 2011 Oct;33(10):1394-9Palliation of recurrent myxofibrosarcoma with radiotherapy and hyperthermia
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2010-11-01 / Singapore Med J 2010 Nov;51(11):e187-90Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
/in Dendritic Cells, International Publications /von 2010-11-01 / Expert Opin Biol Ther 2010 Nov;10(11):1539-53The role of hyperthermia in the battle against cancer
/in Hyperthermia, International Publications /von 2010-11-01 / Tumori 2010 Nov-Dec;96(6):902-10
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de